Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 2
2007 1
2008 1
2011 1
2012 2
2014 1
2015 1
2017 1
2018 1
2021 3
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean alessandro pucciarini[Author] (2 results)?
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, La Starza R, Diverio D, Colombo E, Santucci A, Bigerna B, Pacini R, Pucciarini A, Liso A, Vignetti M, Fazi P, Meani N, Pettirossi V, Saglio G, Mandelli F, Lo-Coco F, Pelicci PG, Martelli MF; GIMEMA Acute Leukemia Working Party. Falini B, et al. Among authors: pucciarini a. N Engl J Med. 2005 Jan 20;352(3):254-66. doi: 10.1056/NEJMoa041974. N Engl J Med. 2005. PMID: 15659725 Free article.
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients.
Venanzi A, Marra A, Schiavoni G, Milner SG, Limongello R, Santi A, Pettirossi V, Ultimo S, Tasselli L, Pucciarini A, Falini L, Sciabolacci S, Martelli MP, Sportoletti P, Ascani S, Falini B, Tiacci E. Venanzi A, et al. Among authors: pucciarini a. Blood Cancer Discov. 2021 May;2(3):216-225. doi: 10.1158/2643-3230.BCD-20-0203. Epub 2021 Apr 10. Blood Cancer Discov. 2021. PMID: 34164626 Free PMC article.
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.
De Propris MS, Musiu P, Intoppa S, Nardacci MG, Pucciarini A, Santi A, Peragine N, Canichella M, De Luca ML, D'Elia GM, Del Giudice I, Pulsoni A, Falini B, Guarini A, Martelli M, Tiacci E, Foà R. De Propris MS, et al. Among authors: pucciarini a. Br J Haematol. 2022 Jul;198(2):e28-e31. doi: 10.1111/bjh.18224. Epub 2022 May 2. Br J Haematol. 2022. PMID: 35499213 No abstract available.
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.
Tiacci E, Ladewig E, Schiavoni G, Penson A, Fortini E, Pettirossi V, Wang Y, Rosseto A, Venanzi A, Vlasevska S, Pacini R, Piattoni S, Tabarrini A, Pucciarini A, Bigerna B, Santi A, Gianni AM, Viviani S, Cabras A, Ascani S, Crescenzi B, Mecucci C, Pasqualucci L, Rabadan R, Falini B. Tiacci E, et al. Among authors: pucciarini a. Blood. 2018 May 31;131(22):2454-2465. doi: 10.1182/blood-2017-11-814913. Epub 2018 Apr 12. Blood. 2018. PMID: 29650799 Free PMC article.
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects.
Assanto GM, Riemma C, Malaspina F, Perrone S, De Luca ML, Pucciarini A, Annechini G, D'Elia GM, Martelli M, Foà R, Tiacci E, Pulsoni A. Assanto GM, et al. Among authors: pucciarini a. Br J Haematol. 2021 Jul;194(1):78-82. doi: 10.1111/bjh.17440. Epub 2021 May 1. Br J Haematol. 2021. PMID: 33932027 Free PMC article.
BRAF mutations in hairy-cell leukemia.
Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, Pucciarini A, Bigerna B, Pacini R, Wells VA, Sportoletti P, Pettirossi V, Mannucci R, Elliott O, Liso A, Ambrosetti A, Pulsoni A, Forconi F, Trentin L, Semenzato G, Inghirami G, Capponi M, Di Raimondo F, Patti C, Arcaini L, Musto P, Pileri S, Haferlach C, Schnittger S, Pizzolo G, Foà R, Farinelli L, Haferlach T, Pasqualucci L, Rabadan R, Falini B. Tiacci E, et al. Among authors: pucciarini a. N Engl J Med. 2011 Jun 16;364(24):2305-15. doi: 10.1056/NEJMoa1014209. Epub 2011 Jun 11. N Engl J Med. 2011. PMID: 21663470 Free PMC article.
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial.
Tiacci E, De Carolis L, Simonetti E, Merluzzi M, Bennati A, Perriello VM, Pucciarini A, Santi A, Venanzi A, Pettirossi V, Schiavoni G, Tasselli L, Ascani S, Volpetti S, Falini B. Tiacci E, et al. Among authors: pucciarini a. Leukemia. 2021 Nov;35(11):3314-3318. doi: 10.1038/s41375-021-01210-8. Epub 2021 Mar 17. Leukemia. 2021. PMID: 33731847 Free PMC article. Clinical Trial. No abstract available.
The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor.
Pettirossi V, Venanzi A, Spanhol-Rosseto A, Schiavoni G, Santi A, Tasselli L, Naccari M, Pensato V, Pucciarini A, Martelli MP, Drexler H, Falini B, Tiacci E. Pettirossi V, et al. Among authors: pucciarini a. Leukemia. 2023 Feb;37(2):473-477. doi: 10.1038/s41375-022-01788-7. Epub 2023 Jan 12. Leukemia. 2023. PMID: 36635390 No abstract available.
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas.
Falini B, Agostinelli C, Bigerna B, Pucciarini A, Pacini R, Tabarrini A, Falcinelli F, Piccioli M, Paulli M, Gambacorta M, Ponzoni M, Tiacci E, Ascani S, Martelli MP, Dalla Favera R, Stein H, Pileri SA. Falini B, et al. Among authors: pucciarini a. Histopathology. 2012 Nov;61(5):930-41. doi: 10.1111/j.1365-2559.2012.04289.x. Epub 2012 Jun 20. Histopathology. 2012. PMID: 22716304
19 results